Published in Vaccine Weekly, March 30th, 2005
Six of the seventeen children who were fully evaluable at the time of the conference were reported to have demonstrated either stable disease or a partial response.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly